Understanding how nicotine affects the brain
Mechanisms of nicotine reinforcement
This work explores the brain pathways that make nicotine addictive, hoping to find new ways to help people stop smoking.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11093454 on NIH RePORTER |
What this research studies
Our previous work showed that a specific brain circuit, called the habenula-interpeduncular nucleus, is very important in how much people want nicotine. We also found that a natural substance in the body, GLP-1, can reduce nicotine cravings by affecting this brain circuit. Now, we are focusing on a gene called Tcf7l2, which appears to play a key role in this GLP-1 signaling and nicotine desire. We are using advanced methods to understand exactly how Tcf7l2 works in the brain to control nicotine intake.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but future clinical applications would target individuals struggling with nicotine dependence.
Not a fit: Patients not affected by nicotine addiction would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to new medications or treatments that target specific brain pathways to help people overcome nicotine addiction.
How similar studies have performed: Previous studies have identified various brain circuits involved in addiction, and this work builds upon those findings by pinpointing specific genes and pathways.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Kenny, Paul J. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Kenny, Paul J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.